China pharma holdings, inc. reports second quarter 2021 financial results

Haikou, china, aug. 13, 2021 /prnewswire/ -- china pharma holdings, inc. (nyse american: cphi)  ("china pharma," the "company" or "we"), an nyse american-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in china, today announced the financial results for the quarter ended june 30, 2021. revenue decreased by 35.9% to $2.4 million for the three months ended june 30, 2021, as compared to $3.8 million for the three months ended june 30, 2020.
CPHI Ratings Summary
CPHI Quant Ranking